key: cord-0269652-coxzlbkp
authors: Cooray, S.; Ranakombu, K.; Enticott, J.; Dawadi, S.; Boyle, J.; Soldatos, G.; Paul, E.; Versace, V.; Teede, H.
title: External validation and updating of a prediction model for the diagnosis of gestational diabetes mellitus
date: 2021-12-07
journal: nan
DOI: 10.1101/2021.12.05.21267329
sha: cba2b494b8a36809b46c6215ecb25e11d6729b73
doc_id: 269652
cord_uid: coxzlbkp

Introduction: The Monash early pregnancy prediction model calculates risks of developing GDM and is internationally externally validated and implemented in practice, however some gaps remain. Objective: To validate and update Monash GDM model, revising ethnicity categorisation, updating to recent diagnostic criteria, to improve performance and generalisability. Methods: Routine health data for singleton pregnancies from 2016 to 2018 in Australia included updated GDM diagnostic criteria. The Original Model predictors were included (age, body mass index, ethnicity, diabetes family history, past-history of GDM, past-history of poor obstetric outcomes, ethnicity), with ethnicity revised. Updating model methods were: recalibration-in-the-large (Model A); re-estimation of intercept and slope (Model B), and; coefficients revision using logistic regression (Mode1 C1 with original eight ethnicity categories, and Mode1 C2 with updated 6 ethnicity categories). Analysis included ten-fold cross-validation, performance measures (c-statistic, calibration-in-the-large value, calibration slope and expected-observed (E:O) ratio) and closed testing examining log-likelihood scores and AIC compared models. Results: In 26,474 singleton pregnancies (4,756, 18% with GDM), we showed that temporal validation of the original model was reasonable (c-statistic 0.698) but with suboptimal calibration (E:O of 0.485). Model C2 was preferred, because of the high c-statistic (0.732), and it performed significantly better in closed testing compared to other models. Conclusions: Updating of the original model sustains predictive performance in a contemporary population, including ethnicity data, recent diagnostic criteria, and universal screening context. This supports the value of risk prediction models to guide risk-stratified care to women at risk of GDM. Trial registration details: This study was registered as part of the PeRSonal GDM study on the Australian and New Zealand Clinical Trials Registry (ACTRN12620000915954); Pre-results.

Gestational diabetes mellitus (GDM), defined as glucose intolerance that develops during pregnancy 1 and is increasing in prevalence. Risk prediction modelling for GDM, undertaken in early pregnancy, offers clinical utility in several scenarios. These include in GDM prevention, by identifying and targeting lifestyle intervention for those at high risk, with 24% reduction in GDM prevalence reported in a meta-analysis of individual participant data. 2 In GDM screening and diagnosis, recommended to enable treatment and reduce pregnancy risks 3, 4 , risk prediction can optimise selective screening by recognising the cumulative and interdependent effects of individual risk factors. Furthermore, an early pregnancy prediction model for the diagnosis of GDM allows personalised risk assessment approaches and riskstratified pregnancy care with targeted delivery of more intensive monitoring and treatment to those at highest risk. 5 In this context, early pregnancy clinical prediction models have been developed to predict the diagnosis of GDM. 6 However, these models require external validation in new settings to demonstrate transportability and are rarely updated to optimise performance for these settings.

The Original 2011 Monash Model (hereafter referred to as the Original Model) was designed to be used in early pregnancy and is now one of multiple available screening tools. 6, 7 Uniquely, it has been independently, externally validated and demonstrated to perform well across diverse populations internationally, across variable diagnostic approaches and criteria. 8 9 Recently, the model has also been updated to include blood glucose levels and clinical utility has been demonstrated using reclassification analysis. 10 It is now applied in clinical practice, facilitated by an accessible simple online tool, especially in the context of reducing oral glucose tolerance tests to those at highest risk to reduce COVID-19 viral transmission exposure at testing. 11 Remaining gaps for the Original Model include external validation and updating in settings where universal screening for GDM is undertaken and diagnosis made using the prevailing International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria. 12 . Since the original model was developed, and with altered diagnostic criteria, GDM has increased with up to a doubling in prevalence, 13 without improved outcomes and there is a need to identify those women within this cohort at highest risk. 14 Also, given ethnicity is a well-established risk factor for the diagnosis of GDM, 15 there is a need to . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint include generalisable ethnicity variables particularly in a multicultural settings such as in Australia. Therefore, here we aimed to externally validate, and if necessary, update the Original Model to predict GDM development applying IADPSG criteria and universal screening. We also aimed to explore the impact of revised ethnicity categories on model performance. Finally we aimed to explore and compare the different approaches to updating risk prediction models to advance the broader risk prediction field.

Here we build on the Original Model that was developed, internally validated, subsequently internationally externally validated and applied clinically. Methods and reporting were guided by the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) statement. 16 We address gaps in model generalisability by using a contemporary population diagnosed with GDM on IADPSG criteria. We performed the following steps:

1. Evaluate the performance of the Original Model in a contemporary population applying IADPSG criteria and universal screening. ii. including revised ethnicity 6 categories -Model C2 3. Finally, a closed testing procedure compared the updated models A, B, C1 and C2 to investigate the method that may best balance performance improvements with extensiveness of model revision. 17 Model performance was evaluated, in terms of discrimination (concordance statistic [c-statistic]) and calibration (calibration-in-thelarge, calibration slope and calibration plot). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

The development and internal validation of the Original Model is previously described. 7 Briefly, a dataset of 2880 singleton pregnancies who delivered at Monash Medical Centre, Melbourne, Australia in 2007 was used to develop the model and internally validated.

Dichotomous outcome was a diagnosis of GDM using modified WHO criteria following the prevailing recommendations of the Australasian Diabetes in Pregnancy Society. 19 The final model included six predictors: age, body mass index (BMI), ethnicity, family history of diabetes, past history of GDM, and poor obstetric outcome. Age and BMI were categorical variables using five age categories and six BMI categories respectively. Ethnicity was classified using an eight-category classification system based on country of birth. The model was presented as a simplified point scoring system, and since was independently externally validated demonstrating sustained performance across diverse populations internationally. [8] [9] [10] The 2021 validation and updating dataset

We used routinely collected health data for singleton pregnancies resulting in a birth from 1 January 2016 to 31 December 2018 at Monash Health. Monash Health is Australia's largest health service and includes three maternity hospitals serving an ethnically diverse population in Melbourne within a universal and freely accessible health system. Maternity, birth, and neonatal data are collected and reported during routine care. We deterministically linked pathology data and clinical data extracted from the medical record.

The data source details are described elsewhere. 20 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint 

The Original Model was developed using complete case analysis. However, this approach can lead to bias and a loss of power. 22 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint

Diagnosis of GDM was defined using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria in a one-step universal screening strategy. 12,23

We evaluated the performance of the Original Model by applying it to a contemporary validation dataset (temporal validation) with GDM. If the Original Model did not perform as well in the contemporary validation as originally, then this would support model updating. 24

We undertook recalibration of the Original Model following three independent model updating methods. 25

Recalibration-in-the-large is a calibration method that is useful when outcome frequency has changed as in this case. The baseline risk of the Original Model is adjusted (i.e. adjusted intercept) to the new dataset. It reflects the differences between the setting in which the model was developed and that to which it is being applied. 24 We estimate a single recalibration factor to correct the average of all predictions effectively shifting the intercept of the calibration plot while the original calibration slope remains unadjusted. 26 As only a single parameter of the Original Model is updated, it is a logical first step.

An updating model method where the intercept and calibration slope from the Original Model are re-estimated. All predictor effects are updated with a single overall correction factor which may potentially account for the new diagnostic criteria, using the method described by Janssen and colleagues. 26 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint

Complete recalibration by revising regression coefficients for all predictor variables using fixed effects multiple logistic regression. We did this twice using (1) the original ethnicity 8 classifications, and (2) new ethnicity 6 reclassifications (Supplementary Table S1 ). The ethnicity classification system was updated to reflect international ethnicity categories with ethnicity self-reported. This differs to the Original Model where ethnicity was extrapolated from country of birth and was intended to improve accuracy and enhance generalisability to other settings. The updated classification system was aligned to the Australian Standard Classification of Cultural and Ethnic Groups. 27 Missing ethnicity were deduced from country of birth and preferred language. This method enables the ethnicity classification system to be updated with a system that is less overfitted to the development dataset and more generalisable to new populations. With this large new dataset from an ethnically diverse population, we had a low likelihood of overfitting. This differs from de novo model development because the predictor selection is based on the original model development study.

Predictive performance measures and a closed testing procedure were examined to select the best model. The performance of the Original Model was temporally validated. Updated Models A, B, C1 and C2 were evaluated using ten-fold cross-validation.

Discrimination, the ability of a model to distinguish a patient with the outcome from those without. 28 was reported using the c-statistic (value 0-1, discriminative if > 0.5). 28 Calibration examines agreement between predicted and observed risks of GDM. We report calibration slopes, calibration-in-the-large values and calibration plots. A calibration slope summarises agreement between predicted and observed risks (value 0-1: values near 1 show accuracy and values < 1 suggest predicted risks that are too extreme). 28 Calibrationin-the-large indicates the extent that predictions are systematically too low or too high, with predicted risks under-estimated if > 0 or over-estimated if < 0). 28 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint As noted by others 17 , particularly in small samples, model performance estimates are often too optimistic when model coefficients are revised using data that wasn't applied in the original model development. Demonstrated in samples with n=278, n=822, and n=2,019 (and larger simulated samples up to n=2,180) the utility of a closed testing procedure to identify the best model less affected by overfitting. 17 It proposes to investigate the update method that may balance the evidence for more extensive updating methods in the validation dataset with the danger of overfitting particularly when small samples sizes are available. 17 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint

The validation dataset consisted of 26,474 singleton pregnancies.

The sample characteristics are in Table 2Error Updated six-category ethnicity system reduced the number of women assigned to the 'other' category as compared to the original eight-category system. Missing data is in Table   2 and was most notable for ethnicity. Ethnicity was deduced for 16,774 women using country of birth and preferred language, both of which had no missing data. In this imputed sample 44.9% were Caucasian, 28.9% Southern and Central Asian, 13.0% South East or North East Asian, and 10.0% North African, Middle Eastern or Sub-Saharan African.

Performance of the Original Model to predict GDM in the new dataset is reported in Table 3 .

Discrimination was reasonable (c-statistic of 0.698, 95% CI: 0.690-0.707). However, the calibration plot demonstrated the predicted risks are too extreme

Performance of the Updated Models are compared to each other and the Original Model in Table 4 . Calibration plots are in Figure 2 . Table 3 . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint

The calibration plot demonstrating the best aligned calibration plot (closely following 45 degree line) was Model B (Figure 2) , showing excellent agreement between predicted and observed risks with a calibration slope of 0.994 and calibration-in-the-large of 0.001 (Table   3 ). Models C1 and C2 also showed excellent calibration, as reflected in calibration slopes of 0.985 and 0.992 respectively and calibration-in-the-large of 0.003 and 0.001, respectively. Models C1 and C2 calibration plots showed excellent agreement over the majority of the predicted probability range, with the exception of slight over estimation of risk at the upper end ( Figure 2 ). However, most women produced probabilities for GDM using Models C1 and C2 in the well calibrated region (mid-to-low risk) as 96% of women had a risk probability of is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint

Here we temporally validate performance and update the Original Model of the Monash early pregnancy prediction for GDM diagnosis. We use large validation and updating datasets derived from a contemporary, ethnically diverse population with GDM diagnosis based on IADPSG criteria and a universal screening strategy, with a GDM prevalence of 18.0%. We applied best practice in ongoing prediction tool updating. First, we evaluated and temporally validated the Original Model which demonstrated acceptable discrimination, but calibration was not optimal, limiting the accuracy of predicted risks. Next, we updated the model using three different methods with progressively greater variation from the Original Model. Model C2 included a six-category self-identified ethnicity system and displayed very good discrimination, while benefitting from a substantial improvement in calibration.

Finally, we compared the updated models to select the best option which best balances is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint selective GDM screening is routine, to more precisely and accurately identify women for OGTT screening who are at higher risk of developing GDM, than the prevailing single riskfactor based approaches. Secondly, this model can be applied in settings where universal screening is routine, such as Australia, to adapt to disaster settings such as limiting OGTT's during the COVID-19 pandemic. 11 Thirdly, this diagnostic model can identify high risk women for targeted preventative lifestyle interventions in past and current clinical trials 29 such as the Bump2Baby and Me trial 30 or ultimately as part of routine care. Finally, it may be used to create a risk-stratified antenatal care pathway, which may be associated with improved perinatal outcomes and cost reduction. 31 Given the controversy and lack of consistency in GDM screening strategies and diagnostic criteria, clinical prediction models for GDM need to be broadly validated in populations and contexts with variability in these factors. Methodologically, validation studies are important prior to implementation. The current study demonstrates that the Original Model had a reasonable c-statistic but the calibration was problematic and overall did not perform well in the new population diagnosed using IADPSG criteria. However, three updated models (B, C1 and C2) performed better, in the population diagnosed using the IADPSG criteria. The current IADPSG criteria are endorsed by the WHO, 32 adopted in many regions including within a universal screening strategy in Australia, 23 and within a selective screening strategy as is common in Europe. 33 The recent external validation of the Original Model done in the Netherlands provides confidence that the predicator variables used in this study performs well in populations diagnosed with GDM using IADPSG criteria, whether by selective or universal screening. 10 The work confirms that model updating, retaining original selected variables, via complete model revision where all coefficients are re-estimated using a large (>25,000) diverse multicultural population dataset, improves both discrimination and calibration of the Original Model. The work also demonstrates that model updating using a large and diverse real-world routine health dataset can produce results similar to the best possible model using the Method B approach 17 . In our case, similar outputs of Models B, C1 and C2 provide evidence that overfitting it unlikely to have occurred in our best model (Model C2), which is extremely important to demonstrate before any clinical utility of the model can be explored (i.e. using this stepped approach in this way is novel and provides important insights into is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint development of robust risk prediction models in large diverse data sets). Noted however is that the methods to undertake Model A and B approaches involve more complex processes as applied statistical software doesn't contain a ready to use program and even when using other investigator provided codes, adapting and verification requires a good understanding of expert coding and statistical theory. Therefore in the supplementary file is the codes that Ethnicity is a well-established risk factor for the development of GDM. 15 However, ethnicity is challenging to classify in contemporary multicultural settings 35 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint internationally. Here we attempted to create a more accurate and generalisable sixcategory system and use self-identified ethnicity rather than the surrogate country of birth.

The strengths of this study include the validation of the Original Model using a large population-based dataset from a contemporary ethnically diverse universal healthcare setting. Secondly, the application of methodological advances has advanced the field and shows how updating models can be done. These methods include the use of multiple imputation and validation using ten-fold cross-validation. Finally, we have updated the GDM model with a view to presenting it in a format that is well-suited to contemporary clinical practice. Previously, clinical prediction models were typically presented as simplified risk Limitations included that this Updated Model handles the continuous variables, BMI and age, as categorical variables. It is accepted that this approach can reduce predictive power of a model and may be superceded by electronic risk calculators. However, re-estimating the relationship between BMI and age as continuous variables and the diagnosis of GDM would arguably result in a completely new prediction model and go beyond a validation and updating process. This highlights the pervading tension between externally validating and updating existing models and developing completely new models which in turn then require further external validation to demonstrate generalisability. 36 In conclusion, this rigorous external validation and model updating study, demonstrates the robustness of this model in early pregnancy, to predict the risk of a diagnosis of GDM across many settings including a population defined by IADPSG criteria within a universal screening strategy and using revised ethnicity categories. We build on the clinical prediction modelling literature to demonstrate the potential value of capitalising on existing validated models by undertaking model updating to sustain predictive performance rather than the de novo . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint development of a new model. Clinically, this builds on the accumulating evidence supporting the integration of this model into routine practice to deliver risk-stratified care to women at risk of GDM across a number of clinical use case scenarios and settings .

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint Tables and Figures   Table 1 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint

A. The original model in the validation dataset . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint D. Updated Model C1 using re-estimation of all coefficients (and the same 8 ethnicity categories in the original model and models A and B).

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 7, 2021. ; https://doi.org/10.1101/2021.12.05.21267329 doi: medRxiv preprint

International Weight Management in Pregnancy Collaborative Group. Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials

A multicenter, randomized trial of treatment for mild gestational diabetes

Effect of treatment of gestational diabetes mellitus on pregnancy outcomes

Prediction modelling to personalise care for gestational diabetes

Prediction models for the risk of gestational diabetes: a systematic review

Gestational diabetes: Development of an early risk prediction tool to facilitate opportunities for prevention

Validation of early risk-prediction models for gestational diabetes based on clinical characteristics

Prognostic models versus single risk factor approach in first-trimester selective screening for gestational diabetes mellitus: a prospective population-based multicentre cohort study

International Association of Diabetes Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy

Adopting the new World Health Organization diagnostic criteria for gestational diabetes: How the prevalence changes in a high-risk region in Australia

Implications of the introduction of new criteria for the diagnosis of gestational diabetes: a health outcome and cost of care analysis

Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement

Australian and New Zealand Clinical Trials Registry [Internet]. The Prediction modelling for Risk-Stratified care for women with Gestational Diabetes (PeRSonal GDM) study: Calculating the individualised risk of adverse outcomes for women with gestational diabetes (ACTRN12620000915954)

Gestational diabetes mellitus --management guidelines. The Australasian Diabetes in Pregnancy Society

Protocol for development and validation of a clinical prediction model for adverse pregnancy outcomes in women with gestational diabetes

The risk of severe postoperative pain: modification and validation of a clinical prediction rule

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

ADIPS Consensus Guidelines for the Testing and Diagnosis of Hyperglycaemia in Pregnancy in Australia and New Zealand. 2014. 24. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating

Validation and updating of predictive logistic regression models: a study on sample size and shrinkage

Updating methods improved the performance of a clinical prediction model in new patients

Australian Bureau of Statistics. 1249.0 -Australian Standard Classification of Cultural and Ethnic Groups (ASCCEG)

Towards better clinical prediction models: seven steps for development and an ABCD for validation

Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: A randomized controlled trial

Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline

Survey by the European Board and College of Obstetrics and Gynaecology on screening for gestational diabetes in Europe

Perioperative Mortality of Elective Abdominal Aortic Aneurysm Surgery

Feasibility of using self-reported ethnicity in pregnancy according to the gestation-related optimal weight classification: a cross-sectional study

Prediction models need appropriate internal, internalexternal, and external validation